1. Home
  2. DATS vs LYRA Comparison

DATS vs LYRA Comparison

Compare DATS & LYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DATS
  • LYRA
  • Stock Information
  • Founded
  • DATS 2014
  • LYRA 2005
  • Country
  • DATS United States
  • LYRA United States
  • Employees
  • DATS N/A
  • LYRA N/A
  • Industry
  • DATS Computer Software: Prepackaged Software
  • LYRA Medical/Dental Instruments
  • Sector
  • DATS Technology
  • LYRA Health Care
  • Exchange
  • DATS Nasdaq
  • LYRA Nasdaq
  • Market Cap
  • DATS 13.4M
  • LYRA 15.0M
  • IPO Year
  • DATS 2021
  • LYRA 2020
  • Fundamental
  • Price
  • DATS $2.56
  • LYRA $8.68
  • Analyst Decision
  • DATS
  • LYRA Buy
  • Analyst Count
  • DATS 0
  • LYRA 2
  • Target Price
  • DATS N/A
  • LYRA $16.00
  • AVG Volume (30 Days)
  • DATS 211.3K
  • LYRA 154.9K
  • Earning Date
  • DATS 08-13-2025
  • LYRA 08-13-2025
  • Dividend Yield
  • DATS N/A
  • LYRA N/A
  • EPS Growth
  • DATS N/A
  • LYRA N/A
  • EPS
  • DATS N/A
  • LYRA N/A
  • Revenue
  • DATS $388.00
  • LYRA $1,185,000.00
  • Revenue This Year
  • DATS N/A
  • LYRA N/A
  • Revenue Next Year
  • DATS N/A
  • LYRA $1,286.17
  • P/E Ratio
  • DATS N/A
  • LYRA N/A
  • Revenue Growth
  • DATS N/A
  • LYRA N/A
  • 52 Week Low
  • DATS $1.04
  • LYRA $3.81
  • 52 Week High
  • DATS $9.34
  • LYRA $37.50
  • Technical
  • Relative Strength Index (RSI)
  • DATS 48.61
  • LYRA 44.53
  • Support Level
  • DATS $2.58
  • LYRA $8.69
  • Resistance Level
  • DATS $2.85
  • LYRA $9.36
  • Average True Range (ATR)
  • DATS 0.14
  • LYRA 0.96
  • MACD
  • DATS 0.00
  • LYRA -0.41
  • Stochastic Oscillator
  • DATS 50.89
  • LYRA 10.87

About DATS DatChat Inc.

DatChat Inc is a blockchain, cybersecurity, and social media company that not only focuses on protecting privacy on personal devices, but also protects user information after it is shared with others. Its mobile messaging application is called DatChat Messenger which is a free messaging application. The platform allows users to exercise control over their messages and posts.

About LYRA Lyra Therapeutics Inc.

Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.

Share on Social Networks: